J Kneer

879 total citations
25 papers, 640 citations indexed

About

J Kneer is a scholar working on Pharmacology, Oncology and Transplantation. According to data from OpenAlex, J Kneer has authored 25 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 11 papers in Oncology and 5 papers in Transplantation. Recurrent topics in J Kneer's work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Drug Transport and Resistance Mechanisms (9 papers) and Renal Transplantation Outcomes and Treatments (5 papers). J Kneer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (12 papers), Drug Transport and Resistance Mechanisms (9 papers) and Renal Transplantation Outcomes and Treatments (5 papers). J Kneer collaborates with scholars based in Switzerland, United States and Germany. J Kneer's co-authors include K. Stoeckel, Robert A. Blouin, Graham Lappin, B. Oosterhuis, R. Jochemsen, W. J. Drijfhout, W. Kuhnz, R E Garner, Damon I. Papac and Rodney G. Keck and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, British Journal of Cancer and Clinical Pharmacology & Therapeutics.

In The Last Decade

J Kneer

25 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Kneer Switzerland 15 224 164 125 109 106 25 640
Stephen A. Bai United States 19 145 0.6× 157 1.0× 83 0.7× 126 1.2× 90 0.8× 34 847
Carol Gleason United States 16 372 1.7× 242 1.5× 37 0.3× 155 1.4× 128 1.2× 43 920
Mitsutaka Kanamaru Japan 15 187 0.8× 140 0.9× 44 0.4× 97 0.9× 90 0.8× 44 698
Benjamin Weber United States 14 103 0.5× 188 1.1× 50 0.4× 220 2.0× 65 0.6× 34 870
Ann Allen United Kingdom 17 233 1.0× 79 0.5× 148 1.2× 92 0.8× 109 1.0× 45 873
M B Affrime United States 14 138 0.6× 95 0.6× 65 0.5× 116 1.1× 120 1.1× 46 765
V. Malerczyk Germany 15 262 1.2× 79 0.5× 74 0.6× 66 0.6× 71 0.7× 46 575
Bindu Murthy United States 14 141 0.6× 64 0.4× 39 0.3× 93 0.9× 61 0.6× 41 672
Renée Portmann Switzerland 13 203 0.9× 163 1.0× 189 1.5× 417 3.8× 102 1.0× 22 789
Donato Teutonico France 12 89 0.4× 125 0.8× 185 1.5× 111 1.0× 47 0.4× 22 674

Countries citing papers authored by J Kneer

Since Specialization
Citations

This map shows the geographic impact of J Kneer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Kneer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Kneer more than expected).

Fields of papers citing papers by J Kneer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Kneer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Kneer. The network helps show where J Kneer may publish in the future.

Co-authorship network of co-authors of J Kneer

This figure shows the co-authorship network connecting the top 25 collaborators of J Kneer. A scholar is included among the top collaborators of J Kneer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Kneer. J Kneer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Andrew J. S., Damon I. Papac, Edward Chin, et al.. (2007). Selective clearance of glycoforms of a complex glycoprotein pharmaceutical caused by terminal N-acetylglucosamine is similar in humans and cynomolgus monkeys. Glycobiology. 17(5). 529–540. 104 indexed citations
2.
Lappin, Graham, W. Kuhnz, R. Jochemsen, et al.. (2006). Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs. Clinical Pharmacology & Therapeutics. 80(3). 203–215. 176 indexed citations
3.
Fürst, Daniel E., Michael H. Weisman, Harold E. Paulus, et al.. (2003). Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.. PubMed. 30(10). 2123–6. 8 indexed citations
4.
Dingemanse, Jasper, J Kneer, Andreas Wallnöfer, et al.. (1996). Pharmacokinetic-Pharmacodynamic Interactions Between Two Selective Monoamine Oxidase Inhibitors: Moclobemide and Selegiline. Clinical Neuropharmacology. 19(5). 399–414. 16 indexed citations
5.
Dingemanse, Jasper, et al.. (1995). Switch in Treatment From Tricyclic Antidepressants to Moclobemide. Journal of Clinical Psychopharmacology. 15(1). 41–48. 10 indexed citations
6.
Borner, M., et al.. (1993). Bioavailability and feasibility of subcutaneous 5-fluorouracil. British Journal of Cancer. 68(3). 537–539. 5 indexed citations
7.
Ha, Huy Riêm, Katharina Rentsch, J Kneer, & Dieter J. Vonderschmitt. (1993). Determination of Midazolam and Its α-Hydroxy Metabolite in Human Plasma and Urine by High-Performance Liquid Chromatography. Therapeutic Drug Monitoring. 15(4). 338–343. 43 indexed citations
8.
Kneer, J. (1993). Relevance of Antibiotic Tissue Penetration in Treating Respiratory Tract Infections. Respiration. 60(1). 32–37. 11 indexed citations
9.
Cullmann, W., et al.. (1992). Cefetamet pivoxil: a review of its microbiology, toxicology, pharmacokinetics and clinical efficacy. International Journal of Antimicrobial Agents. 1(4). 175–191. 18 indexed citations
10.
Brink, H.J. ten, Rob Kok, Frans Stellaard, et al.. (1992). In Vivo Study of Phytanic Acid α-Oxidation in Classic Refsum's Disease and Chondrodysplasia Punctata. Pediatric Research. 32(5). 566–570. 14 indexed citations
11.
Kneer, J. (1992). Pharmacokinetic properties of new oral cephalosporins. Médecine et Maladies Infectieuses. 22. 556–564. 9 indexed citations
12.
Rißler, Klaus, Gerhard Friedrich, & J Kneer. (1991). Determination of the retinoid (E)-1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6-(1-methyl-2-phenylethenyl)naphthalene and its phenolic metabolite in human plasma by reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 565(1-2). 375–382. 5 indexed citations
13.
Hayton, William L., R. A. Walstad, J Kneer, et al.. (1991). Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in children. Antimicrobial Agents and Chemotherapy. 35(4). 720–725. 17 indexed citations
14.
Mönch, E., et al.. (1990). Examination of urine metabolites in the newborn period and during protein loading tests at 6 months of age—part 1. European Journal of Pediatrics. 149(S1). 17–24. 8 indexed citations
15.
Tam, Y.K., J Kneer, U. C. Dubach, & K. Stoeckel. (1990). Effects of timing of food and fluid volume on cefetamet pivoxil absorption in healthy normal volunteers. Antimicrobial Agents and Chemotherapy. 34(8). 1556–1559. 18 indexed citations
16.
Hayton, William L., J Kneer, Robert A. Blouin, & K. Stoeckel. (1990). Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with hepatic cirrhosis. Antimicrobial Agents and Chemotherapy. 34(7). 1318–1322. 11 indexed citations
17.
18.
Stoeckel, K., et al.. (1989). Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review. Current Medical Research and Opinion. 11(7). 432–441. 20 indexed citations
19.
Blouin, Robert A., J Kneer, & K. Stoeckel. (1989). Pharmacokinetics of intravenous cefetamet (Ro 15-8074) and oral cefetamet pivoxil (Ro 15-8075) in young and elderly subjects. Antimicrobial Agents and Chemotherapy. 33(3). 291–296. 33 indexed citations
20.
Kneer, J, Robert A. Blouin, F J Frey, et al.. (1989). Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrobial Agents and Chemotherapy. 33(11). 1952–1957. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen A. Bai Breakdown of academic impact, for papers by Carol Gleason Breakdown of academic impact, for papers by Mitsutaka Kanamaru Breakdown of academic impact, for papers by Benjamin Weber Breakdown of academic impact, for papers by Ann Allen Breakdown of academic impact, for papers by M B Affrime Breakdown of academic impact, for papers by V. Malerczyk Breakdown of academic impact, for papers by Bindu Murthy Breakdown of academic impact, for papers by Renée Portmann Breakdown of academic impact, for papers by Donato Teutonico
Rankless by CCL
2026